Mody Rajal K, Luna-Gierke Ruth E, Jones Timothy F, Comstock Nicole, Hurd Sharon, Scheftel Joni, Lathrop Sarah, Smith Glenda, Palmer Amanda, Strockbine Nancy, Talkington Deborah, Mahon Barbara E, Hoekstra Robert M, Griffin Patricia M
Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Arch Pediatr Adolesc Med. 2012 Oct;166(10):902-9. doi: 10.1001/archpediatrics.2012.471.
To describe pathogens identified through routine clinical practice and factors associated with identifying Shiga toxin-producing Escherichia coli (STEC) infection in patients with postdiarrheal hemolytic uremic syndrome (DHUS).
Population-based active surveillance.
Hospitals in the FoodNet surveillance areas from 2000 through 2010.
Children younger than 18 years with DHUS.
Testing for STEC and demographic and clinical characteristics.
Percentage of patients with evidence of infection with likely HUS-causing agents and associations between exposures and evidence of STEC infection.
Of 617 patients, 436 (70.7%) had evidence of infection with likely HUS-causing agents: STEC O157 (401 patients), non-O157 STEC (21 patients), O157 and non-O157 STEC (1 patient), Streptococcus pneumoniae (11 patients), and other pathogens (2 patients). Among patients without microbiological evidence of STEC, 76.9% of those tested had serologic evidence of STEC infection. Children more likely to have evidence of STEC infections included those patients tested for STEC less than 4 days after diarrhea onset, 12 months or older (71.6% vs 27.8% if <12 months of age), with infections as part of an outbreak (94.3% vs 67.3%), with bloody diarrhea (77.2% vs 40.4%), with onset during June through September (76.9% vs 60.1%), with a leukocyte count greater than 18 000/μL (to convert to ×10(9)/L, multiply by 0.001) (75.7% vs 65.3%), or with only moderate anemia (hemoglobin 7.0 g/dL [to convert to grams per liter, multiply by 10] or hematocrit greater than 20% [to convert to a proportion of 1, multiply by 0.01]) (75.1% vs 66.3%). However, many of these associations were weaker among children with thorough STEC testing.
Early stool collection for E coli O157 culture and Shiga toxin testing of all children with possible bacterial enteric infection will increase detection of STEC strains causing HUS. In the absence of microbiological evidence of STEC, serologic testing should be performed.
描述通过常规临床实践鉴定出的病原体,以及与腹泻后溶血尿毒综合征(DHUS)患者中鉴定出产志贺毒素大肠杆菌(STEC)感染相关的因素。
基于人群的主动监测。
2000年至2010年期间FoodNet监测区域内的医院。
18岁以下的DHUS患儿。
STEC检测以及人口统计学和临床特征。
有感染可能导致溶血尿毒综合征病原体证据的患者百分比,以及暴露因素与STEC感染证据之间的关联。
在617例患者中,436例(70.7%)有感染可能导致溶血尿毒综合征病原体的证据:STEC O157(401例患者)、非O157 STEC(21例患者)、O157和非O157 STEC(1例患者)、肺炎链球菌(11例患者)以及其他病原体(2例患者)。在没有STEC微生物学证据的患者中,76.9%的检测者有STEC感染的血清学证据。更有可能有STEC感染证据的儿童包括腹泻发作后不到4天接受STEC检测的患者、12个月及以上的患者(71.6%对12个月以下患者的27.8%)、作为暴发一部分的感染患者(94.3%对67.3%)、有血性腹泻的患者(77.2%对40.4%)、6月至9月发病的患者(76.9%对60.1%)、白细胞计数大于18000/μL(换算为×10⁹/L,乘以0.001)的患者(75.7%对65.3%),或仅有中度贫血(血红蛋白7.0 g/dL [换算为克/升,乘以10]或血细胞比容大于20% [换算为比例,乘以0.01])的患者(75.1%对66.3%)。然而,在进行全面STEC检测的儿童中,许多这些关联较弱。
对所有可能患有细菌性肠道感染的儿童尽早采集粪便进行大肠杆菌O157培养和志贺毒素检测,将增加对导致溶血尿毒综合征的STEC菌株的检测。在没有STEC微生物学证据的情况下,应进行血清学检测。